121 related articles for article (PubMed ID: 11334920)
1. Role of the follistatin gene in women with polycystic ovary syndrome.
Calvo RM; Villuendas G; Sancho J; San Millán JL; Escobar-Morreale HF
Fertil Steril; 2001 May; 75(5):1020-3. PubMed ID: 11334920
[TBL] [Abstract][Full Text] [Related]
2. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
[TBL] [Abstract][Full Text] [Related]
3. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Brennan K; Huang A; Azziz R
Fertil Steril; 2009 May; 91(5):1848-52. PubMed ID: 18439591
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
6. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
7. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
Kumar A; Woods KS; Bartolucci AA; Azziz R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
10. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
[TBL] [Abstract][Full Text] [Related]
11. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
[TBL] [Abstract][Full Text] [Related]
12. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
Farah-Eways L; Reyna R; Knochenhauer ES; Bartolucci AA; Azziz R
Fertil Steril; 2004 Jan; 81(1):120-5. PubMed ID: 14711554
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome.
Woods KS; Reyna R; Azziz R
Fertil Steril; 2002 Jun; 77(6):1125-7. PubMed ID: 12057716
[TBL] [Abstract][Full Text] [Related]
14. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G; Ozyurek SE; Uncu Y
Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
16. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
18. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
19. Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women.
Calvo RM; Tellería D; Sancho J; San Millán JL; Escobar-Morreale HF
Fertil Steril; 2002 Apr; 77(4):666-8. PubMed ID: 11937112
[TBL] [Abstract][Full Text] [Related]
20. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
